Open AccessQIAGEN TherascreenKRASRGQ Assay, QIAGENKRASPyro Assay, and Dideoxy Sequencing for Clinical Laboratory Analysis ofKRASMutations in Tumor Specimens
Author(s) -
Qamra M. Alqahtani,
Ann M. Crowley,
Sharleen A. Rapp,
Allison M. CushmanVokoun
Publication year - 2016
Publication title -
laboratory medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.332
H-Index - 28
eISSN - 1943-7730
pISSN - 0007-5027
DOI - 10.1093/labmed/lmv009
Subject(s) - kras , microbiology and biotechnology , mutation , detection limit , dna , assay sensitivity , biology , chemistry , gene , medicine , genetics , chromatography , pathology , alternative medicine
To compare the performance of assays used to assess KRAS mutations in tumor specimens.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom